Investors Snag MNTA Even Cheaper Than Its Secondary Stock Offering
May 21, 2015 at 14:42 PM EDT
Looking back to 2 days ago, Momenta Pharmaceuticals Inc (MNTA) priced a 7,250,000 share secondary stock offering at $19.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..